Skip to content

Clinical trials

Attention Deficit Disorder with Hyperactivity trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Attention Deficit Disorder with Hyperactivity Country / region: Belgium Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20051
20071
20083
20091
20104
20112
20121
20141
20161
20171
20191
20202
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Unknown status5
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shire7
Eli Lilly and Company5
Novartis Pharmaceuticals2
Universitaire Ziekenhuizen KU Leuven2
Janssen-Cilag International NV1
Mensia Technologies SA1
Nina Hermans1
Onze Lieve Vrouw Hospital1
Queen Fabiola Children's University Hospital1
University Ghent1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Attention Deficit Disorder with Hyperactivity23
Dyslexia1
Lower Urinary Tract Symptoms1
Motor Skills Disorders1
Neurodevelopmental Disorders1
Oppositional Defiant Disorder1
Spasm1
Urinary Incontinence1

Trials

Showing 26 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.